Sir
Alexander Fleming's discovery of penicillin presented
an exciting challenge for the Mannings people to adapt
this new drug for use in the animal world. In 1948 the
company began producing penicillin intramammaries in
its new facility at the southern end of the city's central
business district. Injectable penicillin for treating
blackleg, footrot and other diseases of sheep and cattle
soon followed. The DURAPEN and PROCAL brands, which
have become household names in the rural community,
are still available today.
Since
Stockguard Laboratories (NZ) Ltd's aquisition of the
business in 1987 the company has continued to expand
and further innovative antibiotic products have been
developed along with other veterinary specialties.
Among the exciting product developments are a number
of world firsts including:
> A long acting vitamin B12 injection, SMARTShot
> A high strength penicillin only intramammary, INTRACILLIN
and
> An injection to treat multi-quarter mastitis infections
with just one treatment, MASTICILLIN.
Stockguard
Laboratories (NZ) Ltd is a private New Zealand company
that specialises in the development and manufacture
of veterinary products. Stockguard Laboratories (NZ)
Ltd is the only manufacturer of veterinary antibiotic
products in New Zealand.
Stockguard
Laboratories (NZ) Ltd has a strong commitment to research
and development to bring through further new innovative
products. Stockguard's valuable contribution at the
forefront of mastitis research and development in
New Zealand is now recognised and supported by government.
A successful bid for funding support under the Grants
for Private Sector Research and Development Scheme
will strengthen Stockguard's ongoing programme to
deliver new and improved mastitis treatments.
With
the continued business growth of Stockguard there
are now two companies.
|
Kevin
Burke & Tony Shergold
